Immunosuppressive low-density neutrophils in the blood of cancer patients display a mature phenotype
Christophe Vanhaver, Frank Aboubakar Nana, Nicolas Delhez, Mathieu Luyckx, Thibault Hirsch, Alexandre Bayard, Camille Houbion, Nicolas Dauguet, Alice Brochier, Pierre van der Bruggen, Annika M. Bruger
Abstract
The presence of human neutrophils in the tumor microenvironment is strongly correlated to poor overall survival. Most previous studies have focused on the immunosuppressive capacities of low-density neutrophils (LDN), also referred to as granulocytic myeloid-derived suppressor cells, which are elevated in number in the blood of many cancer patients. We observed two types of LDN in the blood of lung cancer and ovarian carcinoma patients: CD45 high LDN, which suppressed T-cell proliferation and displayed mature morphology, and CD45 low LDN, which were immature and non-suppressive. We simultaneously evaluated the classical normal-density neutrophils (NDN) and, when available, tumor-associated neutrophils. We observed that NDN from cancer patients suppressed T-cell proliferation, and NDN from healthy donors did not, despite few transcriptomic differences. Hence, the immunosuppression mediated by neutrophils in the blood of cancer patients is not dependent on the cells’ density but rather on their maturity.